|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2011
vol. 113 abstract:
Original paper
Pharmacological treatment of recurrent idiopathic anterior uveitis
Jerzy Szaflik
1
,
Artur Bachta
2
,
Maciej Kulig
2
,
Mateusz Tłustochowicz
3
,
Andrzej Stankiewicz
3
,
Witold Tłustochowicz
2
Klinika Oczna 2011, 113 (2): 111-116
Online publish date: 2011/06/29
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Recurrent anterior uveitis (AU) is an autoimmune disease that in 20% of patients leads to severe visual loss or blindness, thereby a severe disability and significant quality of life impairment. That is why, it is important to conduct a long term treatment after an acute phase of the disease, to keep the remission as long as possible. Up to 50% of patients with recurrent AU have no additional symptoms of systemic disease. This situation, classified as idiopathic AU (IAU), causes a lot of problems when a therapeutic strategy has to be chosen. Nevertheless, IAU is considered to be a first symptom of spondylarthropathy (SpA), even several dozen years prior to other typical manifestations of SpA. There have been published few papers concerning only small groups of patients with IAU, treated with disease modifying anti-rheumatic drugs. The authors present the recommendations for systemic treatment of IAU, based on their own clinical experience, and systematic review of the literature.
keywords:
anterior uveitis, recurrent anterior uveitis, idiopathic anterior uveitis, disease modifying anti-rheumatic drugs |
|
POLSKI
